Xylazine is a non-opioid tranquilizer used in veterinary medicine and is increasingly found as an adulterant in the illicit drug supply. Researchers, public health officials, and community leaders are working to address xylazine in prevention, clinical care, and overdose prevention.
Friday, September 22, 2023 | 1:30–3:00 p.m. ET
Xylazine is a non-opioid sedative not approved for human use that is increasingly found as an adulterant in the illicit drug supply. Researchers, public health officials, and community leaders are working to address xylazine in prevention, clinical care, and overdose prevention.
Presenters during the webinar will discuss the prevalence and toxicology of xylazine, overdose response strategies, and what healthcare professionals and criminal justice practitioners can do to respond. This webinar is sponsored by the Justice Community Opioid Innovation Network (JCOIN) at the National Institute on Drug Abuse (NIDA), in partnership with the Association of State and Territorial Health Officials (ASTHO), and the Addiction Policy Forum.
Richa Ranade, MPH, Senior Director of Overdose Prevention, Association of State and Territorial Health Officials
Mbabazi Kariisa, Ph.D., Health Scientist, Division of Overdose Prevention in National Center for Injury Prevention and Control, Centers for Disease Control and Prevention (CDC)
Traci Green, Ph.D., Professor and Director of the Opioid Policy Research Collaborative, Brandeis University
Megan Reed, Ph.D., MPH, Research Assistant Professor, Thomas Jefferson University
Julia Zur, Ph.D., Program Officer, Services Research Branch, National Institute on Drug Abuse (NIDA)
